IMPLANT SITE NODULE

This adverse event was reported 42 times

These drugs are most commonly taken by patients reporting IMPLANT SITE NODULE:

# Drug Count
0 ETONOGESTREL 28
1 HISTRELIN ACETATE 2
2 TESTOSTERONE 2
3 TESTOSTERONE CYPIONATE 2
4 ADALIMUMAB 1
5 AMIKACIN 1
6 ASPIRIN 1
7 ASPIRIN 325 MG 1
8 ASPIRIN 81 MG 1
9 BIOTIN 1
See all common drugs associated with IMPLANT SITE NODULE

IMPLANT SITE NODULE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HISTRELIN ACETATE 2 0.0023
1 OMADACYCLINE 1 0.0006
2 ETONOGESTREL 28 0.0005
3 TESTOSTERONE CYPIONATE 2 0.0002
4 TIGECYCLINE 1 0.0002
5 CLOFAZIMINE 1 0.0002
6 FOSCARBIDOPA/FOSLEVODOPA 1 0.0001
7 TESTOSTERONE 2 0.0001
8 AMIKACIN 1 0.0001
9 LOVASTATIN 1 0.0000
See all drugs enriched for association with IMPLANT SITE NODULE

IMPLANT SITE NODULE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tetracycline-class Antibacterial [EPC] 1 0.0001
1 Progestin [EPC] 28 0.0001
2 Androgen [EPC] 2 0.0001
3 Antimycobacterial [EPC] 1 0.0000
4 Aminoglycoside Antibacterial [EPC] 1 0.0000
5 Arteriolar Vasodilator [EPC] 1 0.0000
6 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
7 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
8 Vitamin C [EPC] 1 0.0000
9 Platelet Aggregation Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with IMPLANT SITE NODULE